Genentech Oncology
Researching Cancer Immunity Targets
We are actively exploring the potential of disrupting the immunosuppressive processes that promote tumor growth and bolstering the immune system's power to fight cancer.
Explore CD20 CD3
See how targeting CD20 and CD3 can harness the immune system against cancer.
Explore CEA CD3
Learn about the potential of simultaneous binding CEA on tumor cells and CD3 on T cells.
Explore PD-L1
Investigate the PD-L1 pathway and cancer immune evasion.
Explore TIGIT
Learn about targeting the novel TIGIT immune checkpoint and anti-tumor immunity.